Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK. - McCrimmon, Rory J.; Palmer, Karen; Alsaleh, Abdul Jabbar Omar; Lew, Elisheva; Puttanna, Amar (Diabetes Therapy, 2022)